Rebecca Ashfield

I studied at the University of Oxford, and have 20 years' experience in immunotherapy research, spanning academia and industry. I worked for 12 years at Immunocore Ltd developing immunotherapeutics for cancer, and in 2013 returned to the University of Oxford where I work at the Jenner Institute, managing translational vaccine projects. Since 2015 I have been the CSO of Ducentis Biotherapeutics Ltd, developing novel therapies for autoimmune disease and inflammation. I am an external consultant in the fields of vaccine development including GMP manufacture, and cancer immunotherapy.